AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer
Share this article Health Canada Approval Enables Quick and Accurate Blood Testing TORONTO, April 27, 2021 /CNW/ - AA Pharma, a Canadian company focused on legacy pharmaceutical products, has secured the exclusive Canadian rights for the use of a blood analyzer for patients prescribed Clozapine. This medication, indicated for patients with Treatment Resistant Schizophrenia, requires regular blood monitoring. Sight Diagnostics Ⓡ received Health Canada approval for its Sight OLO Ⓡ analyzer, which performs Complete Blood Count (CBC) tests, the most commonly ordered blood test because i...
Source: newswire.ca